Big Blog

Arts & Culture
Biological Science
Blog Watch
Computer Games
Computer Security
Cricket
Data Privacy
Developer
Domain Names
E-commerce
Gadgets
General Science
Handhelds
IP & Patents
Java
Linux
MP3
Nanotech
Online Auctions
Online Legal Issues
Open Source
Personal Finance
Photography
Quirky
Robotics
Search Engines
Space Science
Top Internet
Top Stories
Top Tech
Video Games
Web Developer
Webmaster Tips
XML & Metadata
{Home}



Ancient protein offers clues to killer condition: related news

A General and Rapid Cell-Free Approach for the Interrogation of Protein'Protein, Protein'DNA, and Protein'RNA Interactions and their Antagonists Utilizing Split-Protein Reporters

A General and Rapid Cell-Free Approach for the Interrogation of Protein−Protein, Protein−DNA, and Protein−RNA Interactions and their Antagonists Utilizing Split-Protein Reporters

Ancient Protein Offers Clues To Killer Condition

More than 600 million years of evolution has taken two unlikely distant cousins -- turkeys and scallops - down very different physical paths from a common ancestor. But University of Leeds researchers have found that a motor protein, myosin 2, remains structurally identical in both creatures.

Ancient protein offers clues to killer condition

More than 600 million years of evolution has taken two unlikely distant cousins – turkeys and scallops - down very different physical paths from a common ancestor. But University of Leeds researchers have found that a motor protein, myosin 2, remains structurally identical in both creatures.

Ancient protein offers clues to killer condition

More than 600 million years of evolution has taken two unlikely distant cousins – turkeys and scallops - down very different physical paths from a common ancestor. But University of Leeds researchers have found that a motor protein, myosin 2, remains structurally identical in both creatures.

Ancient protein offers clues to killer condition

More than 600 million years of evolution has taken two unlikely distant cousins – turkeys and scallops - down very different physical paths from a common ancestor.

Deconstructing Green Fluorescent Protein

Green fluorescent protein (GFP) has been reassembled from two pieces, a large fragment 214 amino acids in length that is produced recombinantly (GFP 1−10) and a short synthetic peptide corresponding to the 11th stave of the β-barrel that is 16 amino acids long (synthetic GFP 11), following a system developed by Waldo and co-workers (Cabantous, S.; et al. Nat. Biotechnol. 2005, 23, 102−7) as an in vivo probe for protein association and folding. We demonstrate that the reassembled protein has identical absorption and excited-state proton transfer dynamics as a whole protein of the identical sequence. We show that the reassembled protein can be taken apart and the peptide replaced with a different synthetic peptide designed to perturb the chromophore absorption.

CEM's Sprint™ Rapid Protein Analyzer Provides Protein Determination in Two Minutes

CEM’s Sprint™ Rapid Protein Analyzer provides a protein determination in 2 minutes that is claimed to be more accurate than Kjeldahl and does not use harsh chemicals or high heat.

BioExx Files Process Patent Application for Production of Unique Protein Concentrates and Protein Isolates

BioExx Files Process Patent Application for Production of Unique Protein Concentrates and Protein Isolates

BioExx Files Process Patent Application for Production of Unique Protein Concentrates and Protein Isolates

BioExx Files Process Patent Application for Production of Unique Protein Concentrates and Protein Isolates

Novel Protein Nanoparticles 'Shape' the Future of Disease

Researchers at the University of North Carolina-Chapel Hill (UNC) have granted an exclusive license to Liquidia Technologies for a protein particle fabrication method that could greatly expand the reach of protein therapeutics. Proteins are large organic molecules that perform highly specific and complex functions in the body, making them an ideal instrument to diagnose and cure disease. However, protein solubility, distribution, stability, and aggregation have hampered the development of this therapeutic class.

CHILL OUT AND PLAY LOST PLANET: EXTREME CONDITION COLONIES EDITION FOR XBOX 360AND WINDOWS PCS

SAN MATEO, Calif.— May 28, 2008— Capcom® Entertainment, a leading worldwide developer and publisher of video games, is pleased to announce that Lost Planet: Extreme Condition COLONIES EDITION™ for the Xbox 360® video game and entertainment system from Microsoft and Windows-based PCs is now shipping to retail as part of the Xbox 360 Platinum Hits Program. Lost Planet: Extreme Condition COLONIES EDITION is one of the first games to allow cross platform connectivity from Xbox LIVE® to Games for Windows– LIVE, allowing console and Windows-based PC users to battle it out on the same online battlefield. Lost Planet: Extreme Condition COLONIES EDITION is rated T for Teen by the Entertainment Software Ratings Board (ESRB) and is available as a Platinum Hit for the value price of $29.

An Ancient Protein Balances Gene Activity And Silences Foreign DNA In Bacteria

Compared to humans, bacteria have a much tidier genome. The tiny microorganisms pack their genes closely together, and don't carry around a lot of extraneous DNA, so-called junk DNA that fills in the gaps between genes. Some 90 percent of the complete genome sequence of the bacteria E. coli contains sequences of DNA that code for protein, while 90 percent of the human genome is non--coding junk DNA.

An ancient protein balances gene activity and silences foreign DNA in bacteria

NEW YORK, May 15, 2008 Compared to humans, bacteria have a much tidier genome. The tiny microorganisms pack their genes closely together, and dont carry around a lot of extraneous DNA, so-called junk DNA that fills in the gaps between genes. Some 90 percent of the complete genome sequence of the bacteria E. coli contains sequences of DNA that code for protein, while 90 percent of the human genome is noncoding junk DNA.

Protein predicts Gleevec resistance in gastrointestinal tumors

Excess amounts of a protein called IGF-1R in patients with gastrointestinal stromal tumors (GISTs) could indicate that the patient would be less responsive to the drug imatinib mesylate (known as Gleevec), according to Andrew K. Godwin, Ph.D., a researcher at the Fox Chase Cancer Center in Philadelphia. Preliminary studies have shown that GIST cells, especially Gleevec-resistant cells, might respond well to agents in development for treatment-resistant breast cancer, a form of breast cancer also marked by excessive production of the IGF-1R protein. IGF-1R could also serve as a marker to identify this subset of GIST patients before therapy begins, when alternative treatments would be most effective, the researcher says.

Genetic Clues Offer Hope to Children Who Can't Bear Light St Andrews Team in Breakthrough

SCOTTISH scientists have found clues about the nature of a rare condition which can kill children if they are exposed to daylight.

Elusive Protein Protects Malaria Parasite From Heme

Researchers at the Virginia Bioinformatics Institute (VBI) at Virginia Tech have identified Heme Detoxification Protein (HDP), a unique protein encoded in the malaria genome that represents a potential target for developing new malaria drugs. The team, which includes researchers at Washington University School of Medicine, the United States National Institutes of Health, the United States Food and Drug Administration as well as other researchers at Virginia Tech, has characterized HDP and demonstrated that it plays a major role in protecting Plasmodium as the pathogen pursues infection of its host.

eLayaway offers online retailers a no-fee payment method

Consumers pay a fee equal to 1.9% of the purchase price, taking the place of the fee merchants pay credit and debit card issuers. Consumers can take up to 13 months to pay, and once they do the retailer ships the goods and receives payment. Fledgling online payment service eLayaway offers e-retailers a way to accept payments without paying credit and debit card fees. And it offers consumers a throwback payment method: pay for an item over time, then receive the goods once full payment is made, without the monthly shock of a bloated credit card bill.

Jumsoft offers Aperture Web Themes, Pages Templates 2

Jumsoft has recently released new Aperture Web Themes and Pages Templates 2.0 for iWork, which includes 40 high-quality and professional templates. The new Aperture themes include five separate designs: The Frames Gray Theme produces pictures that have a photo frame, with shadows that imitate the real 3D look of the photo; Grid Black Theme offers a frame for each picture and the gallery appears in a table form that "evokes the image of orderliness;" the iPhone Theme, described as both "modern and calm," frames all pictures and headings together; Rounded Black Theme, similar to the Grid Black Theme, offers a Rounded Black Frame for each picture that separates it from the others; and Mental Image Theme has attractive details for the top and the bottom of your picture gallery or journal pages.

Scientists characterize protein structure of environmentally friendly bacteria

Three dimensional structure of the sensory domain of the bacterium Geobacter sulfurreducens showing two identical protein domains interacting with each other as observed in the crystal structure. The two protein domains are represented as ribbons (li ...

New Role Of Inflammatory Protein In Polycycstic Kidney Disease Identified, Could Lead To Treatment

The Stowers Institute’s Rong Li Lab has discovered that a protein previously shown to have a role in inflammation may also have a role in the formation of cysts in Autosomal Dominant Polycystic Kidney Disease (ADPKD) — one of the most common life-threatening genetic diseases — and has shown that a drug inhibiting the protein can slow the disease in mice.

Arriva Pharmaceuticals Granted Fusion Protein Patent

Arriva Pharmaceuticals, a biopharmaceutical company focused on developing anti-inflammatory therapies, announced today that it had been granted a patent in the U.S. related to a fusion protein with potential applications for treating respiratory diseases. The patent (United States Patent 7,247,704) covers compositions of matter and uses of Aeriva(TM), a fusion protein that combines Secretory Leukocyte Protease Inhibitor (SLPI) and recombinant alpha 1-antitrypsin (rAAT). A similar patent was recently granted by the European Patent Office and will soon issue in several European countries, including the United Kingdom, France and Germany.

'Intrabody' Can Mop Up Mutant Protein In Huntington's Disease Model

Scientists have created a tool for mopping up the clumps of mutant protein that drive neurodegeneration in Huntington's disease. Emory University researchers engineered a virus to make an intracellular antibody or "intrabody" against huntingtin, the protein whose mutant forms poison the brain cells of people with Huntington's.


Search News:


Copyright © 2001-2008 Jonathan Hedley